DK1996160T3 - Bioresorberbar sammensætning med kontrolleret frigivelse - Google Patents
Bioresorberbar sammensætning med kontrolleret frigivelseInfo
- Publication number
- DK1996160T3 DK1996160T3 DK07711943.6T DK07711943T DK1996160T3 DK 1996160 T3 DK1996160 T3 DK 1996160T3 DK 07711943 T DK07711943 T DK 07711943T DK 1996160 T3 DK1996160 T3 DK 1996160T3
- Authority
- DK
- Denmark
- Prior art keywords
- ceramic
- pharmaceutical composition
- preparation
- controlled
- controlled release
- Prior art date
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000000919 ceramic Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 235000011132 calcium sulphate Nutrition 0.000 abstract 1
- 239000001175 calcium sulphate Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 238000001228 spectrum Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600361 | 2006-03-14 | ||
| PCT/EP2007/002250 WO2007104549A2 (en) | 2006-03-14 | 2007-03-14 | Bioresorbable controlled-release composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1996160T3 true DK1996160T3 (da) | 2010-07-05 |
Family
ID=36602790
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07711943.6T DK1996160T3 (da) | 2006-03-14 | 2007-03-14 | Bioresorberbar sammensætning med kontrolleret frigivelse |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8999389B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1996160B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5216601B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101378174B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101431984B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE460154T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2007224651B8 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2644429C (cg-RX-API-DMAC7.html) |
| DE (1) | DE602007005231D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1996160T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2342123T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL193973A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008011606A (cg-RX-API-DMAC7.html) |
| PL (1) | PL1996160T3 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2405537C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007104549A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200807881B (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL181834A (en) | 2006-04-02 | 2011-04-28 | Iscar Ltd | Cutting head and adaptor |
| MX2011005243A (es) * | 2008-11-27 | 2011-08-08 | Lidds Ab | Uso de carboximetilcelulosa para controlar la eyectabilidad y el tiempo de solidificacion de las composiciones que comprenden una o mas ceramicas biorreabsorbibles. |
| JP2012517466A (ja) * | 2009-02-12 | 2012-08-02 | アドゥロ・マテリアル・アクチボラゲット | 制御されたドラッグデリバリーのための生体分解性担体を含む組成物 |
| PT3086784T (pt) * | 2013-12-23 | 2019-06-27 | Bcn Peptides Sa | Análogos de bicalutamida ou (s)-bicalutamida como compostos ativadores de exocitose para utilização no tratamento de um distúrbio de armazenamento lisossómico ou glicogenose |
| JP6758325B2 (ja) | 2015-06-04 | 2020-09-23 | クリティテック・インコーポレイテッド | タキサン粒子およびその使用 |
| CN114767860A (zh) | 2016-04-04 | 2022-07-22 | 克里蒂泰克公司 | 实体肿瘤治疗方法 |
| EP3498675A1 (en) | 2016-10-17 | 2019-06-19 | Lidds AB | A calcium sulphate hemihydrate with unique properties |
| CA3063420A1 (en) | 2017-06-09 | 2018-12-13 | Crititech, Inc. | Treatment of epithelial cysts by intracystic injection of antineoplastic particles |
| AU2018284247B2 (en) | 2017-06-14 | 2020-04-30 | Crititech Inc. | Methods for treating lung disorders |
| CA3076919A1 (en) | 2017-10-03 | 2019-04-11 | Crititech, Inc. | Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer |
| RU2683255C1 (ru) * | 2018-03-06 | 2019-03-27 | Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук | Биоактивный композиционный материал для замещения костных дефектов и способ его получения |
| WO2019170912A1 (en) | 2018-03-09 | 2019-09-12 | Lidds Ab | Bioresorbable controlled-release compositions with sting modulating molecules |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3797758A (en) * | 1972-06-16 | 1974-03-19 | Giulini Gmbh Geb | Method of producing finely dispersed alpha calcium sulfate hemihydrate |
| JP2702953B2 (ja) | 1988-01-30 | 1998-01-26 | オリンパス光学工業株式会社 | 薬液含浸セラミックス |
| EP0376331A3 (en) | 1988-12-29 | 1991-03-13 | Asahi Kogaku Kogyo Kabushiki Kaisha | Slow release drug delivery granules and process for production thereof |
| US5614206A (en) * | 1995-03-07 | 1997-03-25 | Wright Medical Technology, Inc. | Controlled dissolution pellet containing calcium sulfate |
| US8333996B2 (en) | 1995-05-19 | 2012-12-18 | Etex Corporation | Calcium phosphate delivery vehicle and adjuvant |
| US6132463A (en) | 1995-05-19 | 2000-10-17 | Etex Corporation | Cell seeding of ceramic compositions |
| CA2268156C (en) * | 1996-10-16 | 2007-05-29 | Etex Corporation | Bioceramic compositions |
| US6391336B1 (en) * | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| SE9704400D0 (sv) * | 1997-11-28 | 1997-11-28 | Astra Ab | Porous inorganic particles as carriers for drug substances |
| US6030635A (en) * | 1998-02-27 | 2000-02-29 | Musculoskeletal Transplant Foundation | Malleable paste for filling bone defects |
| GB0020610D0 (en) | 2000-08-21 | 2000-10-11 | Dytech Corp Ltd | Uses of porous carriers |
| US6730324B2 (en) * | 2001-04-20 | 2004-05-04 | The University Of British Columbia | Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| SE522749C2 (sv) * | 2002-03-04 | 2004-03-02 | Cerbio Tech Ab | Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning |
| PL1680089T3 (pl) | 2003-10-22 | 2014-03-31 | Lidds Ab | Kompozycja zawierająca biodegradowalną ceramikę hydratującą do kontrolowanego dostarczania leków |
-
2007
- 2007-03-14 AU AU2007224651A patent/AU2007224651B8/en not_active Ceased
- 2007-03-14 US US12/224,942 patent/US8999389B2/en active Active
- 2007-03-14 RU RU2008140519/15A patent/RU2405537C2/ru active
- 2007-03-14 MX MX2008011606A patent/MX2008011606A/es active IP Right Grant
- 2007-03-14 DK DK07711943.6T patent/DK1996160T3/da active
- 2007-03-14 CA CA2644429A patent/CA2644429C/en active Active
- 2007-03-14 JP JP2008558713A patent/JP5216601B2/ja not_active Expired - Fee Related
- 2007-03-14 WO PCT/EP2007/002250 patent/WO2007104549A2/en not_active Ceased
- 2007-03-14 EP EP07711943A patent/EP1996160B8/en active Active
- 2007-03-14 CN CN2007800154671A patent/CN101431984B/zh not_active Expired - Fee Related
- 2007-03-14 ES ES07711943T patent/ES2342123T3/es active Active
- 2007-03-14 AT AT07711943T patent/ATE460154T1/de not_active IP Right Cessation
- 2007-03-14 DE DE602007005231T patent/DE602007005231D1/de active Active
- 2007-03-14 KR KR1020087024798A patent/KR101378174B1/ko not_active Expired - Fee Related
- 2007-03-14 PL PL07711943T patent/PL1996160T3/pl unknown
-
2008
- 2008-09-08 IL IL193973A patent/IL193973A/en active IP Right Grant
- 2008-09-12 ZA ZA200807881A patent/ZA200807881B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR101378174B1 (ko) | 2014-03-27 |
| RU2405537C2 (ru) | 2010-12-10 |
| ATE460154T1 (de) | 2010-03-15 |
| AU2007224651A8 (en) | 2011-10-27 |
| ZA200807881B (en) | 2009-10-28 |
| JP2009529554A (ja) | 2009-08-20 |
| US8999389B2 (en) | 2015-04-07 |
| EP1996160A2 (en) | 2008-12-03 |
| IL193973A (en) | 2012-07-31 |
| PL1996160T3 (pl) | 2010-09-30 |
| KR20080108128A (ko) | 2008-12-11 |
| WO2007104549A2 (en) | 2007-09-20 |
| US20090118215A1 (en) | 2009-05-07 |
| ES2342123T3 (es) | 2010-07-01 |
| CN101431984B (zh) | 2013-07-10 |
| EP1996160B1 (en) | 2010-03-10 |
| HK1129061A1 (en) | 2009-11-20 |
| AU2007224651A1 (en) | 2007-09-20 |
| AU2007224651B8 (en) | 2011-10-27 |
| CN101431984A (zh) | 2009-05-13 |
| MX2008011606A (es) | 2008-09-22 |
| RU2008140519A (ru) | 2010-04-20 |
| WO2007104549A3 (en) | 2007-11-08 |
| WO2007104549A8 (en) | 2007-12-13 |
| DE602007005231D1 (de) | 2010-04-22 |
| EP1996160B8 (en) | 2010-05-12 |
| IL193973A0 (en) | 2009-09-22 |
| JP5216601B2 (ja) | 2013-06-19 |
| AU2007224651B2 (en) | 2011-10-13 |
| CA2644429A1 (en) | 2007-09-20 |
| CA2644429C (en) | 2014-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE460154T1 (de) | Bioresorbierbare zusammensetzung mit kontrollierter freisetzung | |
| WO2006044504A8 (en) | Cgrp receptor antagonists | |
| DK2321321T3 (da) | Triazolo [4,5-d]pyramidinderivater og anvendelse deraf som purinreceptorantagonister | |
| WO2006029153A3 (en) | Monocyclic anilide spirolactam cgrp receptor antagonists | |
| BRPI0715893A2 (pt) | composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono | |
| WO2003028641A3 (en) | Mch receptor antagonists | |
| NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
| MY156822A (en) | Indole derivatives as s1p1 receptor agonists | |
| ATE482210T1 (de) | Oxadiazolderivate als s1p1-rezeptor-agonisten | |
| ATE553105T1 (de) | Azetidin-analoge ais nucleosidase- und phosphorylase-hemmer | |
| WO2006099268A3 (en) | Cgrp receptor antagonists | |
| WO2006031610A3 (en) | Bicyclic anilide spirolactam cgrp receptor antagonists | |
| WO2008112159A3 (en) | Monocyclic anilide spirolactam cgrp receptor antagonists | |
| WO2006031491A3 (en) | Tricyclic anilide spirolactam cgrp receptor antagonists | |
| CU23615B7 (es) | Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| MX2009003926A (es) | Composiciones de fenilalquilamino-carbamato. | |
| NO20090266L (no) | Piperazinylderivater anvendelige i behandlingen av GPR38 receptormedierte sykdommer | |
| DK2018169T3 (da) | Anvendelse af 4,17-beta-dihydroxyandrost-4-en-3-on til behandling af cancer | |
| WO2007146349A3 (en) | Cgrp receptor antagonists | |
| MX2009003929A (es) | Composiciones de fenilalquil carbamato. | |
| WO2005115392A8 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
| WO2006041830A3 (en) | Cgrp receptor antagonists | |
| CO6321157A2 (es) | Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo | |
| WO2006044449A3 (en) | Cgrp receptor antagonists | |
| MX2007001992A (es) | Antagonistas del receptor 5-ht7. |